Skip to main content
OpenTrials

Clinical trial condition

Ann Arbor Stage II Diffuse Large B-Cell Lymphoma

Explore clinical trials studying Ann Arbor Stage II Diffuse Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Ann Arbor Stage II Diffuse Large B-Cell Lymphoma trial results

Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

NCT04139304

Conditions
Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, +13 more
Locations
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas

NCT01193842

Conditions
AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, +39 more
Locations
  • Jackson Hospital and Clinic Montgomery, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

NCT01856192

Conditions
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Locations
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
View all 502 locations
View Trial Details
Active, Not Recruiting

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

NCT03220022

Conditions
AIDS-related Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, +12 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Memorial Hospital West Pembroke Pines, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma

NCT04323956

Conditions
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, +22 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details

Related conditions